CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. – Vertex Pharmaceuticals Incorporated Transaction History
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. portfolio value:
$8.23M
portfolio value
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -52.37% | -31.26K shares | -8.59M | $289.54 | 28.43K |
| Q2 2022 | share | Increase | +97.76% | 29.51K shares | 8.94M | $281.79 | 59.70K |
| Q1 2022 | share | Increase | +35.78% | 7.95K shares | 2.99M | $260.97 | 30.18K |
| Q4 2021 | share | Decrease | -10.02% | -2.47K shares | 400K | $222.45 | 22.23K |
| Q3 2021 | share | Increase | +33.91% | 6.25K shares | 762K | $181.39 | 24.70K |
| Q2 2021 | share | Decrease | -16.79% | -3.72K shares | -1.04M | $201.63 | 18.45K |
| Q1 2021 | share | Decrease | -13.00% | -3.31K shares | -1.25M | $214.89 | 22.17K |
| Q4 2020 | share | Decrease | -52.14% | -27.76K shares | -8.46M | $236.34 | 25.48K |
| Q3 2020 | share | Decrease | -41.89% | -38.39K shares | -12.11M | $272.12 | 53.25K |
| Q2 2020 | share | Decrease | -5.58% | -5.41K shares | 3.51M | $290.31 | 91.65K |
| Q1 2020 | share | Increase | +89.09% | 45.73K shares | 11.85M | $237.95 | 97.06K |
| Q4 2019 | share | Increase | +271.31% | 37.50K shares | 8.89M | $218.95 | 51.33K |
| Q3 2019 | share | Increase | +6.76% | 875 shares | -33K | $169.42 | 13.82K |
| Q2 2019 | share | Increase | +25.42% | 2.62K shares | 476K | $183.38 | 12.95K |
| Q1 2019 | share | Increase | +56.44% | 3.72K shares | 805K | $183.95 | 10.32K |
| Q4 2018 | share | Decrease | -76.88% | -21.95K shares | -4.40M | $165.71 | 6.6K |
| Q3 2018 | share | Decrease | -32.74% | -13.89K shares | -1.71M | $192.74 | 28.55K |
| Q2 2018 | share | Increase | +287.66% | 31.49K shares | 5.43M | $169.96 | 42.44K |
| Q1 2018 | share | Decrease | -18.44% | -2.47K shares | -227K | $162.98 | 10.95K |
| Q4 2017 | share | Increase | +0.56% | 75 shares | -18K | $149.86 | 13.42K |
| Q3 2017 | share | Increase | +33.50% | 3.35K shares | 741K | $152.04 | 13.35K |
| Q2 2017 | share | Increase | +138.10% | 5.8K shares | 830K | $128.87 | 10K |
| Q1 2017 | share | Increase | 0.00% | 4.2K shares | 459K | $109.35 | 4.2K |
| Q2 2016 | share | Decrease | -100.00% | -6.7K shares | -533K | $86.02 | 0 |
| Q1 2016 | share | Increase | +59.52% | 2.5K shares | 5K | $79.49 | 6.7K |